All posts by: Michael Zand

About Michael Zand

BioLineRx (BLRX) Issued US Patent Covering BL-8040 to Obtain Stem Cells – StreetInsider.com (subscription)

BioLineRx (BLRX) Issued US Patent Covering BL-8040 to Obtain Stem CellsStreetInsider.com (subscription)BioLineRx (Nasdaq: BLRX) announced that an Issue Notification has been received from the United States Patent and Trademark Office (USPTO) for US Patent No. 8,455,450, which claims the use of BL-8040’s composition for obtaining hematopoietic … and more …read more   &nbs… Continue reading

2013-09-03 NEWS

RESEARCH AND MARKETS: Hematopoietic Stem Cell Transplantation … – 4-traders (press release)

RESEARCH AND MARKETS: Hematopoietic Stem Cell Transplantation …4-traders (press release)‘Hematopoietic Stem Cell Transplantation – Pipeline Review, H2 2013′, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Hematopoietic Stem Cell Transplantation, complete … and more …read more   &nbs… Continue reading

2013-09-02 NEWS

Harmonizing a broken heart: Stem cells keep cardiac beat in synchrony – Science Daily (press release)

Harmonizing a broken heart: Stem cells keep cardiac beat in synchronyScience Daily (press release)Sep. 1, 2013 — Stem cell therapy used to regenerate injured tissue in the heart restores synchronous pumping, shows research published today [1 September] in The Journal of Physiology. The study proposes a novel strategy of ‘biological … …read more   &nbs… Continue reading

2013-09-02 NEWS